International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018

International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018 (link is external)
Mesh Headings: 
Polycystic Ovary Syndrome |
Guidelines Portal reference number: 
2598
Publication Date: 
2018
Guideline Status: 
Revised
Setting of care: 
Preventive care
Primary/Community care
Secondary care
Population Life Stage: 
Adolescent (13-18 years)
Adult (19-64 years)
Adult, Aged (65+ years)
Intended Users: 
Dietitians
Exercise physiologists
General practitioners
Nurses
Physiotherapists
Psychologists
Sonographers
Other
Population Subgroups considered: 
Aboriginal and Torres Strait Islander people
Culturally and linguistically diverse (CALD) groups
Number of recommendations: 
174
Organisations involved in producing the guideline: 
Organisation: 
Centre for Research Excellence in Polycystic Ovary Syndrome
Involvement in guidelineFurther information icon
Primary Developer
Organisation: 
European Society of Human Reproduction and Embryology
Developer
Organisation: 
American Society for Reproductive Medicine
Developer
Organisation: 
Monash University
Developer
Organisation: 
Androgen Excess and Polycystic Ovary Syndrome Society (ASPCOS)
Endorser
Organisation: 
American Paediatric Endocrine Society
Endorser
Organisation: 
Asia Pacific Paediatric Endocrine Society (APPES)
Endorser
Organisation: 
Asia Pacific Initiative on Reproduction (ASPIRE)
Endorser
Organisation: 
Australasian Paediatric Endocrine Group
Endorser
Organisation: 
Australian Diabetes Society
Endorser
Organisation: 
British Fertility Society (BFS)
Endorser
Organisation: 
Canadian Society of Endocrinology and Metabolism (CSEM)
Endorser
Organisation: 
Dietitians Association of Australia
Endorser
Organisation: 
Endocrine Society (US Endo)
Endorser
Organisation: 
Endocrine Society Australia (ESA)
Endorser
Organisation: 
European Society of Endocrinology (ESE)
Endorser
Organisation: 
European Society for Paediatric Endocrinology (ESPE)
Endorser
Organisation: 
Exercise & Sports Science Australia (ESSA)
Endorser
Organisation: 
Federation of Obstetric and Gynaecological Societies of India (FOGSI)
Endorser
Organisation: 
Fertility Society Australia (FSA)
Endorser
Organisation: 
International Society of Endocrinology (ISE)
Endorser
Organisation: 
International Federation of Fertility Societies (IFFS)
Endorser
Organisation: 
International Federation of Gynaecology and Obstetrics
Endorser
Organisation: 
Societa Italiana di Ginecologia e Ostetricia (SIGO)
Endorser
Organisation: 
The Japanese Society for Pediatric Endocrinology (JSPE)
Endorser
Organisation: 
Jean Hailes Foundation for Women's Health
Endorser
Organisation: 
Sociedad Latinoamericana de Endocrinologia Pediatrica (SLEP)
Endorser
Organisation: 
Nordic Federation of Societies of Obstetrics and Gynaecology (NFOG)
Endorser
Organisation: 
PCOS Challenge: The National Polycystic Ovary Syndrome Association
Endorser
Organisation: 
The PCOS Society (India)
Endorser
Organisation: 
Paediatric Endocrine Society (PES)
Endorser
Organisation: 
Polycystic Ovary Syndrome Association of Australia (POSAA)
Endorser
Organisation: 
Royal Australasian College of Physicians
Endorser
Organisation: 
Royal Australian College of General Practitioners
Endorser
Organisation: 
Royal Australian and New Zealand College of Obstetricians and Gynaecologists
Endorser
Organisation: 
Royal College of Obstetricians and Gynaecologists (RCOG UK)
Endorser
Organisation: 
South African Society of Gynaecology and Obstetrics (SASOG)
Endorser
Organisation: 
Verity UK
Endorser
Organisation: 
Victorian Assisted Reproductive Treatment Authority (VARTA)
Endorser
Systematic Literature Review?Further information icon
Yes
Interest declarationFurther information icon
Yes
Funding statementFurther information icon
Yes
NHMRC ApprovedFurther information icon
Yes
NHMRC Approval valid until: 
Sunday, 2 July 2023
Date of Inclusion: 
07 Sep 2018